Debra Stone
Clinical Nurse Specialist · Claremore, OKNPI 1457463754
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations.
Across 176 payments — averaging $15.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$446
- Alkermes, Inc.$324
- Otsuka America Pharmaceutical, Inc.$317
- Lundbeck LLC$305
- Vanda Pharmaceuticals Inc.$258
- Supernus Pharmaceuticals, Inc.$255
- plus $890 from 8 others
What the payments were for
- Food & beverage$2,781100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $446 |
| Alkermes, Inc. | 18 | $324 |
| Otsuka America Pharmaceutical, Inc. | 22 | $317 |
| Lundbeck LLC | 17 | $305 |
| Vanda Pharmaceuticals Inc. | 12 | $258 |
| Supernus Pharmaceuticals, Inc. | 13 | $255 |
| Teva Pharmaceuticals USA, Inc. | 6 | $215 |
| Ironshore Pharmaceuticals Inc. | 10 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $138 |
| Corium, LLC | 5 | $130 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $105 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Neurocrine Biosciences, Inc. | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$122
How this compares
$2,795 in reported general payments places this provider in the 80th percentile of 56 clinical nurse specialist providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 39 | $24,600 |
| VraylarCariprazine Hcl | 13 | $18,909 |
| Lurasidone Hcl | 26 | $5,726 |
| Paliperidone ErPaliperidone | 11 | $1,846 |
| Aripiprazole | 46 | $1,359 |
| Bupropion XlBupropion Hcl | 32 | $1,210 |
| Duloxetine Hcl | 26 | $1,111 |
| Quetiapine Fumarate | 69 | $1,078 |
| Hydroxyzine Hcl | 25 | $930 |
| Amitriptyline Hcl | 15 | $689 |
| Doxepin Hcl | 22 | $655 |
| Imipramine Hcl | 12 | $640 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 19 | $638 |
| Trazodone Hcl | 52 | $456 |
| Lamotrigine | 27 | $450 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $138 | $24,60039 claims |
| AbbVieVraylar | $446 | $18,90913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 56 clinical nurse specialist providers in Oklahoma.
Other clinical nurse specialist in Claremore
- Deborah CrawfordTulsa$11K
- Stacy BootheNorman$7K
- Jessica GriffithTulsa$5K
- Erica MelickOklahoma City$5K
- Kelly Lang-SheppardOklahoma City$5K
- Cheryl WestOklahoma City$4K
- Melissa DimickTulsa$4K
- Denise BennettOkarche$3K
- Lindsey RemmertTulsa$3K
- Stephanie MooreTulsa$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.